Pharmaceuticals, Biotechnology and Life Sciences
EL PASO, Texas–(BUSINESS WIRE)–TrialSite News LLC (TrialSite), an online news and information platform dedicated to clinical research transparency and accessibility…
Company Outlines Near-Term Priorities AUSTIN, Texas–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today reported financial results for…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…
– Commenced 10-year highly strategic partnership with Gilead to deliver next-generation cancer therapies – Recently announced collaboration with AstraZeneca for…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced interim results from the ongoing SUMMIT trial of neratinib…
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #BGNE–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing…
– Total Revenues of $231.1 Million, Cabozantinib Franchise Revenues of $168.6 Million – – GAAP Diluted EPS of $(0.10), Non-GAAP…
– Company Targeting Enrollment Completion for Pivotal PHYOX™2 Trial of Nedosiran in Fourth Quarter 2020 – – Company Reported $609.9…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30,…
– U.S. LINZESS® (linaclotide) net sales increased 10% year-over-year to $241 million, as reported by AbbVie Inc. (AbbVie) – –…